{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:29:04Z","timestamp":1789075744945,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.transproceed.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T12:01:40Z","timestamp":1715342500000},"page":"953-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency\u2014A One-Center Experience"],"prefix":"10.1016","volume":"56","author":[{"given":"Patrycja","family":"Prokop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Bartoszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gardyszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Kosieradzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Fiedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.transproceed.2024.04.009_bib0001","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.transproceed.2024.04.009_bib0002","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.transproceed.2024.04.009_bib0003","series-title":"Pfaller MA Medical Microbiology","author":"Murray","year":"2015"},{"key":"10.1016\/j.transproceed.2024.04.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2023.200268","article-title":"The human Papillomavirus twilight zone\u2013Latency, immune control and subclinical infection","author":"Doorbar","year":"2023","journal-title":"Tumour Virus Res"},{"issue":"1","key":"10.1016\/j.transproceed.2024.04.009_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.transproceed.2024.04.009_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1112513","article-title":"Human papillomavirus in the setting of immunodeficiency: pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk","volume":"14","author":"Hewavisenti","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.transproceed.2024.04.009_bib0007","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.transproceed.2024.04.009_bib0008","doi-asserted-by":"crossref","first-page":"e14341","DOI":"10.1111\/petr.14341","article-title":"Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence","volume":"26","author":"Nailescu","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1016\/j.transproceed.2024.04.009_bib0009","doi-asserted-by":"crossref","first-page":"e13590","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.transproceed.2024.04.009_bib0010","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/ajt.14181","article-title":"Reactivation of latent HPV infections after renal transplantation","volume":"17","author":"Hinten","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.04.009_bib0011","unstructured":"European Union; Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products"},{"key":"10.1016\/j.transproceed.2024.04.009_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/tgh-19-282","article-title":"Liver transplantation for rare liver diseases and rare indications for liver transplant","volume":"6","author":"Finotti","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2024.04.009_bib0013","series-title":"Fundacja Zjednoczeni dla Transplantacji","article-title":"Zalecenia dotycz\u0105ce leczenia immunosupresyjnego po przeszczepieniu narz\u0105d\u00f3w unaczynionych","author":"Durlik","year":"2010"},{"issue":"5","key":"10.1016\/j.transproceed.2024.04.009_bib0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/labmed-2015-0050","article-title":"Rational laboratory diagnostics of primary immunodeficiency disorders","volume":"39","author":"Hauck","year":"2015","journal-title":"LaboratoriumsMedizin"},{"issue":"6","key":"10.1016\/j.transproceed.2024.04.009_bib0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.anai.2021.08.413","article-title":"Secondary immunodeficiencies: an overview","volume":"127","author":"Tuano","year":"2021","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524002446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524002446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:41:08Z","timestamp":1730824868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524002446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0041134524002446"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.04.009","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency\u2014A One-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}